Press release -
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012- 2018
With growing incidences of cancer, Parkinson’s and Alzheimer’s disease, and metabolic disorders, the global peptide therapeutics market has received a significant boost. The application of peptide therapeutics in the field of biotechnology and pharmaceuticals offers tremendous potential as an emerging market and the research report analyses the numerous possibilities that lie before the global peptide therapeutics market.
Browse Report:http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Categorizing the peptide therapeutics market on the basis of type, application, route of administration, technology, and geography, the report individually evaluates each segment of the peptide therapeutics industry and offers key insights on the same. Data on key aspects such as market size, value, industry share, global outlook, trends, and past, current, and future statistics of the global peptide therapeutics market have been provided and analyzed with the help of graphs, tables, and pie-charts.
The
report also identifies growth drivers, inhibitors and opportunities
of the peptide therapeutics market, with a detailed section covering
the competitive landscape.
Overview of the global peptide therapeutics market
The worldwide market for peptide therapeutics was valued at US$14.1 billion in 2011 and is expected to grow to US$25.4 billion in 2018 at a CAGR of 8.7% during the forecast period.
The
prevalence of cancer, Alzheimer’s and Parkinson’s disease, and
metabolic disorders has grown in recent years, which has propelled
the peptide therapeutics market. Moreover, based on market research,
the integration of small peptide therapeutics firms and large
pharmaceutical companies will pose tremendous opportunities for
growth. In addition to this, possibility of patent cliff in the
forecast period is expected to expand the generic peptide segment.
Advances in technology, increasing R&D activities in the field of
peptide therapeutics, and development of cancer vaccines are some of
the other forces that drive the global peptide therapeutics market.
The factors that restrain the growth of the peptide therapeutics
market are difficulties in corresponding equipment with patients’
needs, growing intricacies of peptides, and poor regulatory standards
for peptide therapeutics.
Peptide
therapeutics are applied in numerous disciplines of medicine such as
anti-infection, neurology, cardiovascular, renal, pain, dermatology,
respiratory, cancer, gastro intestinal, and metabolic. Of these,
cancer peptide enjoys the largest industry share, accounting for 21%
of the overall peptide therapeutics market. However, with increasing
prevalence of Alzheimer’s and Parkinson’s disease, the
neuropeptide segment is expected to witness rapid growth in the
forecast period. Among the major routes of peptide therapeutics
administration, the parenteral segment made up for 86% of the market
share in 2011. Globally, North America dominates the global peptide
therapeutics market, making up 40% of the overall industry.
Companies
mentioned in the research report
The
vendors operating in the global peptide therapeutics market include
F. Hoffmann La Roche Ltd., Novo-Nordisk A/S, Eli Lilly and Company,
Ipsen, and Amylin Pharmaceuticals LLC (Bristol-Myers Squibb). The
CMOs in the global peptide therapeutics market include Peptisyntha,
Inc., Lonza, Inc., Bachem Holding AG, and PolyPeptide Group.
Major
geographies analyzed under this research report are:
-
Europe
-
North America
-
Asia-Pacific
-
Rest of the World
This
report gives you access to decisive data such as:
-
Market growth drivers
-
Factors limiting market growth
-
Current market trends
-
Market structure
-
Market projections for the coming years
Key highlights of this report:
-
Overview of key market forces propelling and restraining market growth
-
Up-to-date analyses of market trends and technological improvements in the micro servers industry
-
Pin-point analyses of market competition dynamics to offer you a competitive edge
-
An analysis of strategies of major competitors
-
An array of graphics and SWOT analysis of major industry segments
-
Detailed analyses of industry trends
-
A well-defined technological growth map with an impact-analysis
-
Offers a clear understanding of the competitive landscape and key product segments
Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418
Topics
- Business enterprise, General
Regions
- Albany
About Us :
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
marketresearchreports-biz